Polydopamine nanoparticles kill cancer cells

[EN]Polydopamine (PD) is a synthetic melanin analogue of growing importance in the eld of biomedicine, especially with respect to cancer research, due, in part, to its biocompatibility. But little is known about the cytotoxic e ects of PD on cancer cell lines. PD is a UV-vis absorbing material whose...

Full description

Bibliographic Details
Authors: Nieto Jiménez, Celia; Vega Moreno, Milena Amparo; Marcelo, Gema; Martín del Valle, Eva María
Format: Article
Status:Published version
Publication date:2018
Country:España
Institution:Universidad de Salamanca (USAL)
Repository:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/169278
Online Access:http://hdl.handle.net/10366/169278
Access Level:Open access
Keyword:Polidopamina
Nanopartículas
Sistemas transportadores
Nanomedicina
Nanomedicine
Nanoparticles
3312 Tecnología de Materiales
3303 Ingeniería y Tecnología Químicas
nanopartículas
nanomedicina
Description
Summary:[EN]Polydopamine (PD) is a synthetic melanin analogue of growing importance in the eld of biomedicine, especially with respect to cancer research, due, in part, to its biocompatibility. But little is known about the cytotoxic e ects of PD on cancer cell lines. PD is a UV-vis absorbing material whose absorbance overlaps with that of formazan salts, which are used to assess cell viability in MTT assays. In this study, a protocol has been established to eliminate the contributing absorbance of PD at 550 nm, and has been applied to characterize the cytotoxicity of PD nanoparticles in both healthy and breast cancer cell lines. Once the protocol is applied, it was found that PD is per se an antineoplastic system, meaning it selectively kills cancer cells, especially those of breast cancer, but it has no toxic effect on healthy cells. The mechanism of action could be related to the production of ROS and the alteration of iron homeostasis in lysosomes. To the best of our knowledge there are only a few examples of nanoparticle systems devoid of drugs that selectively kill cancer cells.